Evidence map›Paper›PMID 30267118›Full record

ArticleHerz2020

[Lipid profile and cardiovascular risk of participants in the lipid measurement program in the industrial park in Höchst].

M Christmann, A Rosada, K Ferlinz, P Bramlage, E Steinhagen-Thiessen

Abstract read
PubMed Publisher
In one paragraph

Article in Herz, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M ChristmannSanofi-Aventis Deutschland GmbH, Frankfurt, Deutschland.
A RosadaKlinik für Geriatrie und Altersmedizin, Charité Campus Benjamin Franklin, Berlin, Deutschland.
K FerlinzSanofi-Aventis Deutschland GmbH, Berlin, Deutschland. klaus.ferlinz@sanofi.com.
P BramlageInstitut für Pharmakologie und Präventive Medizin, Cloppenburg, Deutschland.ORCID http://orcid.org/0000-0003-4970-2110
E Steinhagen-ThiessenMedizinische Klinik für Endokrinologie und Stoffwechselmedizin, Charité, Berlin, Deutschland.

Funding

Sanofi-Aventis Deutschland GmbH n.a.
6 · The paper itself

Abstract

backgroundCardiovascular (CV) diseases are still the most frequent cause of death in industrial nations. Employer-initiated screening of the CV risk could make an early contribution to optimization of the prevention strategies.

methodsIn a cross-sectional study the CV risk profile (e.g., dyslipidemia, hypertension, smoking, diabetes mellitus and familial disposition) of 1436 employees at the industrial park in Frankfurt Höchst was analyzed. The total risk was estimated using the PROCAM score.

resultsA hypercholesterolemia (low-density lipoprotein, LDL >130 mg/dl) was detected in 36% of the participants. Of the high-risk participants (myocardial infarct, apoplexy and/or diabetes) 23.7% (n = 9/38) were in the target range for LDL as defined by the European Society of Cardiology (ESC) of below 70 mg/dl, 18.4% (n = 7) had levels between 70 and 100 mg/dl and 57.9% (n = 22) had levels of more than 100 mg/dl. In addition, more than half of the subjects (53.2%) had increased blood pressure values (defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg). The prevalence of diabetes (blood sugar >126 mg/dl) was very low (1.3%) as was the frequency of manifest CV diseases (1.4% myocardial infarct or apoplexy, 2.9% stabile angina pectoris or peripheral arterial occlusive disease, PAOD).

conclusionThe data confirm that the risk factors high blood pressure and dyslipidemia are widespread and the achievement of target values is insufficient, particularly with a high risk of CV. Behavioral therapeutic and/or pharmaceutical measures should be instigated in order to better exploit the high preventive potential for carriers of these risk factors.

Indexed as

Cardiovascular DiseasesDyslipidemiasCross-Sectional StudiesHumansLipidsRisk FactorsLipidsCardiovascular preventionDyslipidemiasEmployer-initiated screeningHypertensionLow-density lipoprotein

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.